Structure

Physi-Chem Properties

Molecular Weight:  715.45
Volume:  750.268
LogP:  4.784
LogD:  3.739
LogS:  -3.258
# Rotatable Bonds:  32
TPSA:  188.7
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  2
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.017
Synthetic Accessibility Score:  4.021
Fsp3:  0.632
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.521
MDCK Permeability:  3.185003515682183e-05
Pgp-inhibitor:  0.084
Pgp-substrate:  0.992
Human Intestinal Absorption (HIA):  0.975
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  95.96111297607422%
Volume Distribution (VD):  1.221
Pgp-substrate:  1.259883999824524%

ADMET: Metabolism

CYP1A2-inhibitor:  0.12
CYP1A2-substrate:  0.123
CYP2C19-inhibitor:  0.258
CYP2C19-substrate:  0.044
CYP2C9-inhibitor:  0.556
CYP2C9-substrate:  0.943
CYP2D6-inhibitor:  0.297
CYP2D6-substrate:  0.087
CYP3A4-inhibitor:  0.874
CYP3A4-substrate:  0.016

ADMET: Excretion

Clearance (CL):  8.576
Half-life (T1/2):  0.073

ADMET: Toxicity

hERG Blockers:  0.287
Human Hepatotoxicity (H-HT):  0.324
Drug-inuced Liver Injury (DILI):  0.053
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.749
Maximum Recommended Daily Dose:  0.825
Skin Sensitization:  0.639
Carcinogencity:  0.111
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.036

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC256689

Natural Product ID:  NPC256689
Common Name*:   Nocardichelin B
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  XWMNRKXRGYSMGY-YWIDYDFISA-N
Standard InCHI:  InChI=1S/C38H61N5O8/c1-2-3-4-5-6-7-8-9-10-11-14-23-35(46)42(49)28-19-12-17-26-39-34(45)24-25-36(47)43(50)29-20-13-18-27-40-37(48)32-30-51-38(41-32)31-21-15-16-22-33(31)44/h14-16,21-23,32,44,49-50H,2-13,17-20,24-30H2,1H3,(H,39,45)(H,40,48)/b23-14-/t32-/m0/s1
SMILES:  CCCCCCCCCCC/C=CC(=O)N(CCCCCN=C(CCC(=O)N(CCCCCN=C([C@@H]1COC(=N1)c1ccccc1O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL228574
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000347] Amino acids and derivatives
            • [CHEMONTID:0000060] Alpha amino acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33043 nocardia strain acta 3026 Species 0cardiaceae Bacteria n.a. n.a. n.a. PMID[17536856]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT196 Cell Line AGS Homo sapiens TGI = 1500.0 nM PMID[522256]
NPT196 Cell Line AGS Homo sapiens GI50 = 44.7 nM PMID[522256]
NPT65 Cell Line HepG2 Homo sapiens TGI = 335.4 nM PMID[522256]
NPT65 Cell Line HepG2 Homo sapiens GI50 = 69.9 nM PMID[522256]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 1130.0 nM PMID[522256]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3490.0 nM PMID[522256]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC256689 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC123011
0.7622 Intermediate Similarity NPC5932
0.7469 Intermediate Similarity NPC39431
0.7468 Intermediate Similarity NPC81026
0.7436 Intermediate Similarity NPC197921
0.7425 Intermediate Similarity NPC472923
0.7407 Intermediate Similarity NPC262166
0.7405 Intermediate Similarity NPC266741
0.7389 Intermediate Similarity NPC91953
0.7389 Intermediate Similarity NPC469360
0.7301 Intermediate Similarity NPC56685
0.7284 Intermediate Similarity NPC473491
0.7278 Intermediate Similarity NPC254700
0.7261 Intermediate Similarity NPC471201
0.7251 Intermediate Similarity NPC475204
0.7251 Intermediate Similarity NPC40234
0.7251 Intermediate Similarity NPC475123
0.7244 Intermediate Similarity NPC6570
0.7235 Intermediate Similarity NPC107938
0.7235 Intermediate Similarity NPC294516
0.7215 Intermediate Similarity NPC476989
0.7212 Intermediate Similarity NPC244509
0.7205 Intermediate Similarity NPC16188
0.7168 Intermediate Similarity NPC137627
0.7161 Intermediate Similarity NPC328070
0.7152 Intermediate Similarity NPC322526
0.7151 Intermediate Similarity NPC46009
0.7151 Intermediate Similarity NPC196091
0.7134 Intermediate Similarity NPC233702
0.7126 Intermediate Similarity NPC279871
0.7126 Intermediate Similarity NPC26108
0.7126 Intermediate Similarity NPC471165
0.7124 Intermediate Similarity NPC17374
0.7115 Intermediate Similarity NPC169766
0.711 Intermediate Similarity NPC230611
0.7102 Intermediate Similarity NPC475421
0.7091 Intermediate Similarity NPC5194
0.7091 Intermediate Similarity NPC202198
0.7091 Intermediate Similarity NPC261934
0.7089 Intermediate Similarity NPC473055
0.7089 Intermediate Similarity NPC473052
0.7083 Intermediate Similarity NPC244336
0.7069 Intermediate Similarity NPC273755
0.7069 Intermediate Similarity NPC306804
0.7067 Intermediate Similarity NPC474862
0.7059 Intermediate Similarity NPC218323
0.7055 Intermediate Similarity NPC317254
0.7052 Intermediate Similarity NPC473693
0.7052 Intermediate Similarity NPC471568
0.7035 Intermediate Similarity NPC473502
0.7029 Intermediate Similarity NPC158277
0.7029 Intermediate Similarity NPC155506
0.7029 Intermediate Similarity NPC473354
0.7029 Intermediate Similarity NPC476227
0.7029 Intermediate Similarity NPC473402
0.7029 Intermediate Similarity NPC159767
0.7025 Intermediate Similarity NPC43755
0.7013 Intermediate Similarity NPC296712
0.7006 Intermediate Similarity NPC105541
0.7006 Intermediate Similarity NPC269750
0.7006 Intermediate Similarity NPC194671
0.7006 Intermediate Similarity NPC132308
0.7 Intermediate Similarity NPC315542
0.6995 Remote Similarity NPC477526
0.6994 Remote Similarity NPC135121
0.6994 Remote Similarity NPC186617
0.6989 Remote Similarity NPC50016
0.6983 Remote Similarity NPC167763
0.6983 Remote Similarity NPC470112
0.6983 Remote Similarity NPC470903
0.6982 Remote Similarity NPC287757
0.6982 Remote Similarity NPC319320
0.6975 Remote Similarity NPC201244
0.6975 Remote Similarity NPC477217
0.6971 Remote Similarity NPC248670
0.697 Remote Similarity NPC324081
0.6962 Remote Similarity NPC473360
0.6957 Remote Similarity NPC83289
0.6957 Remote Similarity NPC212850
0.6957 Remote Similarity NPC189724
0.6954 Remote Similarity NPC268348
0.6943 Remote Similarity NPC274732
0.6941 Remote Similarity NPC476194
0.6936 Remote Similarity NPC302597
0.6928 Remote Similarity NPC171372
0.6923 Remote Similarity NPC323336
0.6923 Remote Similarity NPC329731
0.6923 Remote Similarity NPC326349
0.6923 Remote Similarity NPC4910
0.6923 Remote Similarity NPC56635
0.6919 Remote Similarity NPC63931
0.6914 Remote Similarity NPC328494
0.691 Remote Similarity NPC45037
0.6909 Remote Similarity NPC245974
0.6909 Remote Similarity NPC132771
0.6906 Remote Similarity NPC299806
0.6905 Remote Similarity NPC476268
0.6905 Remote Similarity NPC473580
0.689 Remote Similarity NPC247298
0.6882 Remote Similarity NPC59827
0.6882 Remote Similarity NPC184933
0.6879 Remote Similarity NPC246079
0.6879 Remote Similarity NPC61004
0.6875 Remote Similarity NPC242159
0.6875 Remote Similarity NPC313694
0.6867 Remote Similarity NPC283760
0.6863 Remote Similarity NPC476260
0.6863 Remote Similarity NPC476241
0.686 Remote Similarity NPC289776
0.686 Remote Similarity NPC191863
0.686 Remote Similarity NPC133470
0.6852 Remote Similarity NPC477837
0.6852 Remote Similarity NPC477838
0.6851 Remote Similarity NPC294951
0.6842 Remote Similarity NPC471203
0.6835 Remote Similarity NPC471953
0.6835 Remote Similarity NPC470392
0.6833 Remote Similarity NPC473404
0.6833 Remote Similarity NPC476321
0.6828 Remote Similarity NPC328763
0.6824 Remote Similarity NPC207675
0.6824 Remote Similarity NPC212699
0.6818 Remote Similarity NPC476125
0.6818 Remote Similarity NPC476179
0.6815 Remote Similarity NPC120251
0.6813 Remote Similarity NPC196708
0.6813 Remote Similarity NPC64205
0.6811 Remote Similarity NPC473407
0.6811 Remote Similarity NPC473378
0.6802 Remote Similarity NPC241794
0.68 Remote Similarity NPC129486
0.6797 Remote Similarity NPC477151
0.6797 Remote Similarity NPC132518
0.6796 Remote Similarity NPC471526
0.6795 Remote Similarity NPC477839
0.6791 Remote Similarity NPC471563
0.6781 Remote Similarity NPC227553
0.6778 Remote Similarity NPC32064
0.6776 Remote Similarity NPC473051
0.6776 Remote Similarity NPC473050
0.6772 Remote Similarity NPC477527
0.6772 Remote Similarity NPC326966
0.6768 Remote Similarity NPC106183
0.6759 Remote Similarity NPC258056
0.6758 Remote Similarity NPC471050
0.6758 Remote Similarity NPC471049
0.6758 Remote Similarity NPC471048
0.6757 Remote Similarity NPC283207
0.6747 Remote Similarity NPC9373
0.6744 Remote Similarity NPC475544
0.6744 Remote Similarity NPC469243
0.6743 Remote Similarity NPC328649
0.6742 Remote Similarity NPC164608
0.6742 Remote Similarity NPC165285
0.6731 Remote Similarity NPC476353
0.673 Remote Similarity NPC244866
0.6727 Remote Similarity NPC473804
0.6723 Remote Similarity NPC83241
0.6723 Remote Similarity NPC89831
0.6721 Remote Similarity NPC138083
0.672 Remote Similarity NPC281629
0.6711 Remote Similarity NPC17388
0.6711 Remote Similarity NPC476183
0.6711 Remote Similarity NPC289330
0.6711 Remote Similarity NPC471308
0.6711 Remote Similarity NPC53596
0.6711 Remote Similarity NPC160120
0.6708 Remote Similarity NPC127741
0.6707 Remote Similarity NPC315283
0.6707 Remote Similarity NPC476444
0.6707 Remote Similarity NPC314388
0.6705 Remote Similarity NPC66490
0.6705 Remote Similarity NPC156348
0.6688 Remote Similarity NPC213969
0.6688 Remote Similarity NPC165726
0.6687 Remote Similarity NPC231572
0.6687 Remote Similarity NPC150712
0.6687 Remote Similarity NPC119569
0.6685 Remote Similarity NPC475532
0.6685 Remote Similarity NPC276120
0.6684 Remote Similarity NPC323662
0.6667 Remote Similarity NPC476281
0.6667 Remote Similarity NPC257390
0.6667 Remote Similarity NPC471447
0.6667 Remote Similarity NPC316008
0.6667 Remote Similarity NPC61332
0.6667 Remote Similarity NPC473305
0.6667 Remote Similarity NPC86966
0.6667 Remote Similarity NPC163961
0.6667 Remote Similarity NPC7817
0.6667 Remote Similarity NPC29531
0.6667 Remote Similarity NPC476184
0.6667 Remote Similarity NPC240130
0.6667 Remote Similarity NPC239357
0.6667 Remote Similarity NPC475168
0.6667 Remote Similarity NPC77992
0.6667 Remote Similarity NPC307682
0.6667 Remote Similarity NPC313867
0.6648 Remote Similarity NPC209463
0.6648 Remote Similarity NPC136797

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC256689 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7407 Intermediate Similarity NPD7131 Phase 3
0.719 Intermediate Similarity NPD4207 Discontinued
0.7161 Intermediate Similarity NPD5729 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD4208 Discontinued
0.7107 Intermediate Similarity NPD1725 Approved
0.7101 Intermediate Similarity NPD7318 Phase 3
0.7093 Intermediate Similarity NPD7485 Phase 3
0.7093 Intermediate Similarity NPD7484 Phase 3
0.7052 Intermediate Similarity NPD7608 Discontinued
0.7027 Intermediate Similarity NPD1759 Phase 1
0.7024 Intermediate Similarity NPD7118 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD4149 Clinical (unspecified phase)
0.6994 Remote Similarity NPD3692 Discontinued
0.6982 Remote Similarity NPD7317 Phase 3
0.6974 Remote Similarity NPD3676 Clinical (unspecified phase)
0.6959 Remote Similarity NPD1758 Phase 1
0.6957 Remote Similarity NPD7978 Discontinued
0.6923 Remote Similarity NPD3136 Phase 2
0.6914 Remote Similarity NPD6681 Discovery
0.6892 Remote Similarity NPD3123 Discovery
0.6879 Remote Similarity NPD1048 Approved
0.6875 Remote Similarity NPD6894 Phase 1
0.6848 Remote Similarity NPD3281 Clinical (unspecified phase)
0.6842 Remote Similarity NPD6668 Clinical (unspecified phase)
0.6835 Remote Similarity NPD520 Approved
0.6826 Remote Similarity NPD1975 Clinical (unspecified phase)
0.6816 Remote Similarity NPD7695 Clinical (unspecified phase)
0.6813 Remote Similarity NPD1772 Clinical (unspecified phase)
0.6807 Remote Similarity NPD4357 Discontinued
0.677 Remote Similarity NPD3555 Approved
0.677 Remote Similarity NPD3554 Approved
0.677 Remote Similarity NPD3553 Approved
0.677 Remote Similarity NPD3552 Approved
0.6768 Remote Similarity NPD6860 Clinical (unspecified phase)
0.6766 Remote Similarity NPD5348 Clinical (unspecified phase)
0.674 Remote Similarity NPD5192 Clinical (unspecified phase)
0.673 Remote Similarity NPD839 Approved
0.673 Remote Similarity NPD840 Approved
0.673 Remote Similarity NPD7477 Discontinued
0.6727 Remote Similarity NPD5481 Discontinued
0.6726 Remote Similarity NPD6390 Discontinued
0.6726 Remote Similarity NPD4186 Clinical (unspecified phase)
0.6724 Remote Similarity NPD8031 Discontinued
0.6721 Remote Similarity NPD6045 Phase 3
0.671 Remote Similarity NPD2079 Discontinued
0.6687 Remote Similarity NPD7450 Phase 2
0.6686 Remote Similarity NPD8303 Discontinued
0.6686 Remote Similarity NPD6862 Phase 2
0.6667 Remote Similarity NPD2517 Approved
0.6667 Remote Similarity NPD3421 Phase 3
0.6667 Remote Similarity NPD1770 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2592 Discontinued
0.6649 Remote Similarity NPD4466 Phase 1
0.6647 Remote Similarity NPD6884 Clinical (unspecified phase)
0.663 Remote Similarity NPD5557 Phase 1
0.6628 Remote Similarity NPD3796 Clinical (unspecified phase)
0.6627 Remote Similarity NPD7613 Discontinued
0.6627 Remote Similarity NPD7303 Discontinued
0.6625 Remote Similarity NPD5745 Approved
0.661 Remote Similarity NPD2516 Approved
0.6609 Remote Similarity NPD7080 Clinical (unspecified phase)
0.6607 Remote Similarity NPD1786 Approved
0.6607 Remote Similarity NPD1787 Approved
0.6607 Remote Similarity NPD6087 Phase 1
0.6607 Remote Similarity NPD1785 Approved
0.6606 Remote Similarity NPD7596 Clinical (unspecified phase)
0.6605 Remote Similarity NPD8173 Phase 2
0.6605 Remote Similarity NPD8172 Phase 2
0.6603 Remote Similarity NPD3125 Approved
0.659 Remote Similarity NPD8019 Approved
0.6588 Remote Similarity NPD1670 Discontinued
0.6578 Remote Similarity NPD6377 Clinical (unspecified phase)
0.6568 Remote Similarity NPD2505 Approved
0.6568 Remote Similarity NPD2504 Approved
0.6562 Remote Similarity NPD3056 Clinical (unspecified phase)
0.6559 Remote Similarity NPD6089 Clinical (unspecified phase)
0.6556 Remote Similarity NPD5200 Clinical (unspecified phase)
0.6552 Remote Similarity NPD7972 Discontinued
0.6548 Remote Similarity NPD6609 Clinical (unspecified phase)
0.6532 Remote Similarity NPD6072 Discontinued
0.6524 Remote Similarity NPD6866 Clinical (unspecified phase)
0.6524 Remote Similarity NPD6867 Clinical (unspecified phase)
0.6519 Remote Similarity NPD7451 Discontinued
0.6519 Remote Similarity NPD3909 Discontinued
0.6509 Remote Similarity NPD6682 Clinical (unspecified phase)
0.6506 Remote Similarity NPD3655 Clinical (unspecified phase)
0.65 Remote Similarity NPD6919 Clinical (unspecified phase)
0.65 Remote Similarity NPD5746 Approved
0.6494 Remote Similarity NPD7011 Discontinued
0.6494 Remote Similarity NPD2423 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7523 Phase 3
0.6488 Remote Similarity NPD2219 Phase 1
0.6481 Remote Similarity NPD8416 Discontinued
0.6481 Remote Similarity NPD6346 Approved
0.6478 Remote Similarity NPD1712 Approved
0.6477 Remote Similarity NPD7565 Approved
0.6474 Remote Similarity NPD6502 Phase 2
0.6474 Remote Similarity NPD5108 Clinical (unspecified phase)
0.6461 Remote Similarity NPD2041 Clinical (unspecified phase)
0.6461 Remote Similarity NPD2042 Clinical (unspecified phase)
0.645 Remote Similarity NPD160 Clinical (unspecified phase)
0.6444 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6441 Remote Similarity NPD2098 Approved
0.6436 Remote Similarity NPD4435 Approved
0.6436 Remote Similarity NPD3490 Discontinued
0.6429 Remote Similarity NPD1662 Clinical (unspecified phase)
0.642 Remote Similarity NPD2415 Discontinued
0.642 Remote Similarity NPD6405 Approved
0.642 Remote Similarity NPD5967 Approved
0.642 Remote Similarity NPD2379 Clinical (unspecified phase)
0.642 Remote Similarity NPD6407 Approved
0.642 Remote Similarity NPD1423 Approved
0.6417 Remote Similarity NPD3153 Approved
0.6417 Remote Similarity NPD3154 Approved
0.6411 Remote Similarity NPD8059 Phase 3
0.6411 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6407 Remote Similarity NPD7153 Discontinued
0.6402 Remote Similarity NPD3052 Approved
0.6402 Remote Similarity NPD3054 Approved
0.64 Remote Similarity NPD821 Approved
0.6395 Remote Similarity NPD3033 Phase 2
0.6392 Remote Similarity NPD7810 Phase 3
0.6392 Remote Similarity NPD6325 Discontinued
0.6392 Remote Similarity NPD7811 Phase 3
0.6389 Remote Similarity NPD4652 Approved
0.6386 Remote Similarity NPD6032 Approved
0.6384 Remote Similarity NPD3674 Clinical (unspecified phase)
0.6383 Remote Similarity NPD4434 Approved
0.6375 Remote Similarity NPD2040 Clinical (unspecified phase)
0.6374 Remote Similarity NPD7447 Phase 1
0.6374 Remote Similarity NPD5556 Clinical (unspecified phase)
0.6369 Remote Similarity NPD2459 Approved
0.6369 Remote Similarity NPD6746 Phase 2
0.6369 Remote Similarity NPD2584 Suspended
0.6369 Remote Similarity NPD2460 Phase 3
0.6369 Remote Similarity NPD2458 Approved
0.6368 Remote Similarity NPD5525 Clinical (unspecified phase)
0.6364 Remote Similarity NPD5946 Clinical (unspecified phase)
0.6364 Remote Similarity NPD5773 Approved
0.6364 Remote Similarity NPD2226 Clinical (unspecified phase)
0.6364 Remote Similarity NPD696 Discontinued
0.6364 Remote Similarity NPD5772 Approved
0.6364 Remote Similarity NPD2200 Suspended
0.6358 Remote Similarity NPD4911 Discontinued
0.6358 Remote Similarity NPD1329 Clinical (unspecified phase)
0.6358 Remote Similarity NPD1330 Phase 2
0.6354 Remote Similarity NPD2388 Discontinued
0.6353 Remote Similarity NPD6666 Approved
0.6353 Remote Similarity NPD6667 Approved
0.6352 Remote Similarity NPD1131 Approved
0.6352 Remote Similarity NPD1135 Approved
0.6352 Remote Similarity NPD1133 Approved
0.6352 Remote Similarity NPD1129 Approved
0.6352 Remote Similarity NPD1134 Approved
0.6349 Remote Similarity NPD2792 Approved
0.6348 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6348 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6348 Remote Similarity NPD8070 Approved
0.6347 Remote Similarity NPD3656 Approved
0.6344 Remote Similarity NPD7132 Clinical (unspecified phase)
0.6343 Remote Similarity NPD2541 Clinical (unspecified phase)
0.6343 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6341 Remote Similarity NPD654 Phase 3
0.634 Remote Similarity NPD5292 Approved
0.634 Remote Similarity NPD5291 Approved
0.6339 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6339 Remote Similarity NPD5940 Clinical (unspecified phase)
0.6337 Remote Similarity NPD2184 Approved
0.6337 Remote Similarity NPD2183 Approved
0.6335 Remote Similarity NPD596 Approved
0.6335 Remote Similarity NPD600 Approved
0.6333 Remote Similarity NPD2890 Approved
0.6333 Remote Similarity NPD2888 Approved
0.6333 Remote Similarity NPD2017 Approved
0.6333 Remote Similarity NPD2889 Approved
0.6331 Remote Similarity NPD3400 Discontinued
0.6329 Remote Similarity NPD1421 Approved
0.6329 Remote Similarity NPD1420 Approved
0.6328 Remote Similarity NPD7494 Clinical (unspecified phase)
0.6328 Remote Similarity NPD7738 Approved
0.6328 Remote Similarity NPD2097 Approved
0.6328 Remote Similarity NPD7737 Approved
0.6325 Remote Similarity NPD1753 Discontinued
0.6324 Remote Similarity NPD3823 Discontinued
0.6322 Remote Similarity NPD3111 Phase 1
0.6322 Remote Similarity NPD824 Approved
0.6319 Remote Similarity NPD2674 Phase 3
0.6319 Remote Similarity NPD3451 Clinical (unspecified phase)
0.6316 Remote Similarity NPD595 Approved
0.6316 Remote Similarity NPD7213 Phase 3
0.6316 Remote Similarity NPD593 Approved
0.6316 Remote Similarity NPD7212 Phase 2
0.6307 Remote Similarity NPD6844 Discontinued
0.6307 Remote Similarity NPD7495 Discontinued
0.6306 Remote Similarity NPD5338 Clinical (unspecified phase)
0.6303 Remote Similarity NPD2157 Approved
0.6296 Remote Similarity NPD4738 Phase 2
0.6294 Remote Similarity NPD4971 Clinical (unspecified phase)
0.6294 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6294 Remote Similarity NPD6863 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data